Home | Publications | Country | Asia / Pacific | Hong Kong place holder
place holder place holder

Hong Kong

The Pharmaceutical Market: Hong Kong


Publication Date   July 2006
Publisher   Espicom
Product Type   Report
Pages   76
ISBN Number   not applicable
Product Code   ESP432
Ask a question about this product?

Price £595.00

approximately: $1,112 | €755

Summary


With a population of around 6.8 million, Hong Kong is really a city state, but the high level of wealth means that its healthcare provisions are of the very highest standard. Along with Singapore, Hong Kong ranks as one of Asia's most prosperous economies. The territory acts as a hub for trade throughout the region, and especially as a conduit for trade in and out of the People's Republic of China, although this role has arguably lost some of its importance due to the rapid business development on the mainland.

Hong Kong's healthcare system was severely tested by the outbreak of SARS in 2003 and led to efforts being implemented to strengthen the system in the event of a reoccurrence. Understandably, infectious disease prevention is a key focus of various investment and training programmes. Besides SARS, waiting lists and financial constraints in particular have affected healthcare development in recent years, with the main emphasis being on cost containment, greater involvement of the private sector and increased patient contributions.

The pharmaceutical market is limited by the size of the population, but is receptive to use of the latest drugs. The healthcare system remains organised along similar lines to that in the UK, with similarly high levels of care. There is a significant level of local manufacturing, although this is restricted to cheap generic products. Advanced drugs tend to be imported.

Content


Background Data

  • Geography
  • Political Overview
  • Economic Overview
  • Population
    • Population in Census Years,
    • Population by Council District,
  • Demographic Indicators
    • Principal Demographic Indicators,
  • Mortality
    • Leading Causes of Death,
  • Morbidity
    • Cancer
    • Newly Registered Cases of Cancer,
    • Infectious Diseases
    • Reported Infectious Diseases,
    • HIV/AIDS
    • SARS
  • Charts
    • Map of Hong Kong
    • Population by Age Group, 2004 (%)
    • Causes of Death, 2002 (%)
    • Summary of SARS Cases & Deaths: February - May
    • ?Espicom

Healthcare System

  • Organisation & Administration
  • Health Expenditure
    • Hospital Authority Expenditure
    • Hospital Authority Budget Allocation, 2000/01 - 2002/03 (HK$ millions)
    • HA Budget Allocation by Hospital, 2001/02 (HK$ millions)
    • Resource Utilisation by Hospital Clusters, 2002/
    • Department of Health Expenditure
    • Department of Health Expenditure, 1999/00-2001/02 (HK$ millions)
  • Hospital Services
    • Hospital Beds by Type of Institution, 1995/96-2002/
    • Hospital Authority Beds, 2000/01-2003/
    • Private Hospital Beds,
    • Hospital Beds by Specialty,
    • Hospital Activity
    • Inpatient Discharges,
    • Hospital Authority Inpatient Activity, 1997/98-2002/
    • Hospital Discharges by Specialty (ICD10),
  • Ambulatory Care
    • DoH General Outpatient Attendances,
    • General & Specialist Outpatient Attendances, 2002/
    • Outpatient Attendances by Type and Region,
    • Specialist DoH Clinic VIsits, 1997-2002/
    • Dental Services
    • General Dental Services & Attendances,
    • Hospital Authority Outpatient Departments
    • Specialist Hospital Authority Outpatient Attendances, 1998/99-2002/
  • Medical Personnel
    • Registered Medical Personnel, 31st March
    • Hospital Authority Personnel
    • Hospital Authority Personnel,
    • Hospital Doctors by Specialty,
  • Charts
    • Hospital Authority Expenditure by Category, 2001/02 (%)
    • ?Espicom
  • Accessing The Pharmaceutical
  • Market

Accessing The Pharmaceutical Market

  • Introduction
  • Regulatory Environment
    • Activities of Pharmaceutical Service,
    • Pharmaceutical Registration
    • Traditional Chinese Medicine (TCM)
    • The Chinese Medicine Council of Hong Kong
    • Patent Protection & Intellectual Property Rights
    • Patents & generics
    • Local concerns
    • Pricing and Reimbursement
  • Distribution Channels
  • Domestic Production
    • VIda Laboratories
    • Hong Kong Association of the Pharmaceutical Industry (HKAPI)
    • Leading Drug Manufacturers & Pharmaceuticals
    • 2003 Top 10 Manufacturers
    • 2003 Top 10 Products
    • Research & Development
  • Directory
    • Government Organisations
    • Trade Associations
  • Charts
    • Registered Domestic Pharmaceutical Manufacturers,